Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00087802
Status:
COMPLETED
Last Update Posted:
2009-04-16
First Post:
2004-07-13
Brief Title:
GemcitabineOxaliplatin GEMOX vs CarboplatinPaclitaxel CP in Non-Small Cell Lung Cancer NSCLC
Sponsor:
Sanofi
Organization:
Sanofi
Organization Data
Organization:
Sanofi
Class:
INDUSTRY
Study ID:
L_9210
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sanofi
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Study Director
Old Organization:
sanofi-aventis